Login to Your Account

Lundbeck Acquiring Synaptic, CNS Pipeline For $121M In Cash

By Brady Huggett

Friday, November 22, 2002
Synaptic Pharmaceutical Corp. signed a definitive merger agreement with like-minded central nervous system-focused H. Lundbeck A/S in a deal worth about $121 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription